Hemogenyx Pharmaceuticals.
33 announcements.
33 announcements.
Time | Date | Ticker | Company | Announcement |
---|---|---|---|---|
12:49 | 22-11-2024 | HEMO | Hemogenyx Pharmaceuticals | Notice of Extraordinary General Meeting |
07:00 | 22-11-2024 | HEMO | Hemogenyx Pharmaceuticals | IRB Approval for Phase I Clinical Trial |
07:00 | 11-11-2024 | HEMO | Hemogenyx Pharmaceuticals | Institutional Investment |
07:00 | 30-10-2024 | HEMO | Hemogenyx Pharmaceuticals | Schedule for Phase I Clinical Trial Opening |
11:19 | 02-10-2024 | HEMO | Hemogenyx Pharmaceuticals | Strategic Investment from Prevail Partners, LLC |
07:00 | 27-09-2024 | HEMO | Hemogenyx Pharmaceuticals | Half-year Report |
07:00 | 09-09-2024 | HEMO | Hemogenyx Pharmaceuticals | FLT3 Assay Ready for Phase I Trials at MD Anderson |
07:00 | 02-09-2024 | HEMO | Hemogenyx Pharmaceuticals | CDX Development Update |
07:00 | 28-08-2024 | HEMO | Hemogenyx Pharmaceuticals | Presentation at CBD S&T Conference |
16:39 | 27-06-2024 | HEMO | Hemogenyx Pharmaceuticals | Result of Annual General Meeting |
07:00 | 17-06-2024 | HEMO | Hemogenyx Pharmaceuticals | Operations Update |
07:00 | 03-06-2024 | HEMO | Hemogenyx Pharmaceuticals | Posting of Annual Report & Notice of AGM |
07:00 | 25-04-2024 | HEMO | Hemogenyx Pharmaceuticals | Final Results |
07:00 | 28-03-2024 | HEMO | Hemogenyx Pharmaceuticals | Total Voting Rights |
07:00 | 29-02-2024 | HEMO | Hemogenyx Pharmaceuticals | Placing to Raise US$4.2 million |
07:00 | 16-02-2024 | HEMO | Hemogenyx Pharmaceuticals | CBR Brain Delivery |
07:00 | 14-02-2024 | HEMO | Hemogenyx Pharmaceuticals | CBR Intranasal Delivery |
07:00 | 09-02-2024 | HEMO | Hemogenyx Pharmaceuticals | FDA Consents to Phase I Trials of HEMO-CAR-T |
07:00 | 02-02-2024 | HEMO | Hemogenyx Pharmaceuticals | Approval and Issuance of U.S. Conditioning Patent |
07:00 | 16-01-2024 | HEMO | Hemogenyx Pharmaceuticals | Submission of Complete Response to Clinical Hold |
07:00 | 08-01-2024 | HEMO | Hemogenyx Pharmaceuticals | HEMO-CAR-T Process Qualification Run Completed |
12:19 | 28-11-2023 | HEMO | Hemogenyx Pharmaceuticals | Placing to Raise £534,375 |
07:00 | 27-11-2023 | HEMO | Hemogenyx Pharmaceuticals | CBR Expanded to Treatment of Cancer |
07:00 | 15-11-2023 | HEMO | Hemogenyx Pharmaceuticals | Lentivirus Re-manufacturing Completed |
07:00 | 31-10-2023 | HEMO | Hemogenyx Pharmaceuticals | Total Voting Rights |
12:28 | 28-09-2023 | HEMO | Hemogenyx Pharmaceuticals | Half-year Report |
07:00 | 18-09-2023 | HEMO | Hemogenyx Pharmaceuticals | Strategic Investment from Prevail Partners, LLC |
07:00 | 14-09-2023 | HEMO | Hemogenyx Pharmaceuticals | Clinical Hold Lift Plan is accepted by FDA |
07:00 | 10-07-2023 | HEMO | Hemogenyx Pharmaceuticals | Full FDA Review for HEMO-CAR-T IND |
16:07 | 30-06-2023 | HEMO | Hemogenyx Pharmaceuticals | Result of Annual General Meeting |
14:01 | 02-06-2023 | HEMO | Hemogenyx Pharmaceuticals | Posting of Annual Report & Notice of AGM |
11:24 | 02-06-2023 | HEMO | Hemogenyx Pharmaceuticals | Clinical Hold on IND for HEMO-CAR-T |
07:00 | 09-05-2023 | HEMO | Hemogenyx Pharmaceuticals | Submission of IND for HEMO-CAR-T |